Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV)

CUSIP: 603380205

Q3 2023 13F Holders as of 30 Sep 2023

Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
45,675,986
Total 13F shares
2,403,051
Share change
+50,751
Total reported value
$16,580,809
Price per share
$6.90
Number of holders
19
Value change
+$303,012
Number of buys
8
Number of sells
6

Quarterly Holders Quick Answers

What is CUSIP 603380205?
CUSIP 603380205 identifies NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of NERV - Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FEDERATED HERMES, INC.
13F
Company
3%
1,351,275
$9,896,738 30 Jun 2023
13F
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
3/4/5
10%+ Owner
class O/S missing
1,275,000
$4,794,000 27 Jun 2023
FMR LLC
13F
Company
1.1%
491,746
$4,494,558 30 Jun 2023
13F
VANGUARD GROUP INC
13F
Company
0.45%
205,154
$1,875,108 30 Jun 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.22%
98,300
$898,000 30 Jun 2023
13F
BlackRock Finance, Inc.
13F
Company
0.17%
78,831
$720,516 30 Jun 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.11%
51,964
$474,950 30 Jun 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.05%
21,463
$195,000 30 Jun 2023
13F
Virtu Financial LLC
13F
Company
0.05%
20,993
$192,000 30 Jun 2023
13F
STATE STREET CORP
13F
Company
0.03%
13,719
$125,392 30 Jun 2023
13F
MORGAN STANLEY
13F
Company
0.02%
8,995
$82,215 30 Jun 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.01%
4,517
$41,285 30 Jun 2023
13F
WELLS FARGO & COMPANY/MN
13F
Company
0%
1,976
$18,060 30 Jun 2023
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
1,254
$11,462 30 Jun 2023
13F
Russell Investments Group, Ltd.
13F
Company
0%
1,175
$10,739 30 Jun 2023
13F
UBS Group AG
13F
Company
0%
434
$3,967 30 Jun 2023
13F
ROYAL BANK OF CANADA
13F
Company
0%
218
$2,000 30 Jun 2023
13F
TFC Financial Management, Inc.
13F
Company
0%
186
$1,701 30 Jun 2023
13F
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
13F
Company
0%
100
$914 30 Jun 2023
13F
Anchor Investment Management, LLC
13F
Company
0%
12
$110 30 Jun 2023
13F
BARCLAYS PLC
3/4/5
10%+ Owner
class O/S missing
605,230
11 Aug 2022
Jeryl L. Hilleman
3/4/5
Director
class O/S missing
12,500
27 Sep 2023
William F. Doyle
3/4/5
Director
class O/S missing
2,500
10 Jun 2022

Institutional Holders of Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) as of Q3 2023

As of 30 Sep 2023, Minerva Neurosciences, Inc. - Common Stock, par value $0.0001 per share (NERV) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,403,051 shares. The largest 10 holders included FEDERATED HERMES, INC., FMR LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., UBS OCONNOR LLC, GEODE CAPITAL MANAGEMENT, LLC, ACADIAN ASSET MANAGEMENT LLC, STATE STREET CORP, and MORGAN STANLEY. This page lists 19 institutional shareholders reporting positions in this security for the Q3 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2023 vs Q2 2023 Across Filers

Q2 2023 holders
18
Q3 2023 holders
19
Holder diff
1
Investor Q2 2023 Shares Q3 2023 Shares Share Diff Share Chg % Q2 2023 Value $ Q3 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .